Showing results (61-70 of 104) with videos related to
Sort By:
Pageof 11
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1996
Lack of pharmacokinetic interaction between pantoprazole and diclofenacH Bliesath, R Huber, V W Steinijans, et al.International Journal of Clinical Pharmacology and Therapeutics|May 1, 1996
Pantoprazole does not interact with nifedipine in man under steady-state conditionsH Bliesath, R Huber, V W Steinijans, et al.International Journal of Clinical Pharmacology and Therapeutics|April 1, 1996
Lack of pharmacokinetic interaction between pantoprazole and diclofenacH Bliesath, R Huber, V W Steinijans, et al.Pneumologie (Stuttgart, Germany)|November 1, 1991
[Efficacy of a theophylline retard preparation administered at 3 different intake times additionally to basic medication]B Siebert, G Kunkel, K Borner, et al.International Journal of Clinical Pharmacology and Therapeutics|February 1, 1996
Pantoprazole does not interact with nifedipine in man under steady-state conditionsH Bliesath, R Huber, V W Steinijans, et al.Pneumologie (Stuttgart, Germany)|November 1, 1991
[Pharmacokinetics and pharmacodynamics of twice-daily unequal administration of theophylline retard pellets in children of various age groups]D Berdel, A von Berg, D Reinhardt, et al.International Journal of Clinical Pharmacology and Therapeutics|June 1, 1995
Lacking effect of grapefruit juice on theophylline pharmacokineticsU Fuhr, A Maier, A Keller, et al.International Journal of Clinical Pharmacology and Therapeutics|May 11, 1999
Pantoprazole lacks induction of CYP1A2 activity in manM Hartmann, K Zech, H Bliesath, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1992
Bioequivalence studies: single vs multiple doseV W Steinijans, R Sauter, J H Jonkman, et al.Biopharmaceutics & Drug Disposition|March 1, 1989
Sustained release properties of the once daily theophylline capsule BY912 as compared with Theo-24 capsulesJ H Jonkman, V W Steinijans, W Beier, et al.Pageof 11